Microfluidic modulation spectroscopy sales will rise through 2036, driven by drug designing at a 42.6% share in 2026 as the leading application segment. The market was valued at USD 201 million in 2025 and is expected to reach USD 493.09 million by 2036, creating an incremental opportunity of USD 275.01 million.